Terawaki Y, Nomiyama T, Takahashi H, Tsutsumi Y, Murase K, Nagaishi R, et al
Firstly, through a systematic review and network meta-analysis, researchers have assessed the effects of GLP-1R agonists on neuroinflammation and reported that, compared with placebo, GLP-1R agonists significantly reduce the levels of neuroinflammatory markers, such as TNF- and interleukin-1 (Urkon et al., 2025
L-carnitine facilitates the mitochondrial eta-oxidation process and energy production by mediating the transport of long-chain fatty acids into the mitochondrial matrix (Ribas et al
Potential benefits of MOTS-c: Improved insulin sensitivity Better glucose control Increased exercise capacity Enhanced mitochondrial function Improved metabolic flexibility Unlike Semaglutide or Tirzepatide, MOTS-c does not primarily work by reducing appetite
Understanding how GLP-1 medication influences these pathways can provide insights into its effectiveness in suppressing appetite and aiding weight loss